Beckman Coulter Integrates Vi-CELL™ XR Analyzer for Fully Automated Cell Culture Applications

Integrated automation adds flexibility to the application of the Vi-CELL instrument, from basic cellular research through drug development and scaleup and even into pharmaceutical manufacturing quality control. The Vi-CELL XR (extended range) measures the viability of cells and counts them in minutes, using the widely accepted Trypan Blue cell viability tissue culture protocol. The instrument measures 15 to 30 times more volume than competitive systems in the same amount of time, with a more comprehensive array of parameters. The automated, integrated solution monitors cell growth over time.

Beckman Coulter’s Integrated Solutions Group developed the customized solution for a cell culture “seed and feed” application. Components of the solution include the Vi-CELL XR, a Biomek® NXP workstation configured with a Span-8 Pod and gripper, a Biomek® FXP dual-bridge workstation, storage devices, incubator, plate hotel and two detectors. The integrated solution provides cell analysis data necessary to evaluate clone selection, cell expansion and protein expression results. Data from the analysis is also automatically captured for subsequent analysis with other cellular results that determine cell viability and efficiency such as confluence, loci of growth and protein-protein interactions.

“No other cell viability analyzer can be integrated for this level of automation,” explained Karen Bezold, director of research flow cytometry and business development for Beckman Coulter. “Because Beckman Coulter’s total product offering is so broad, we are uniquely qualified to provide complete solutions and support to our customers. This capability gives our users additional downstream application options for their easy-to-use Vi-CELL instruments.”

“Beckman Coulter’s Vi-CELL XR Cell Viability Analyzer with its extended, 2 – 70 µ size range, reagent-saving 500 µL sample volume and enhanced image resolution can now be utilized in fully automated cell culture systems with walk-away operation for the monitoring and optimization of cell growth,” commented Bob Lund, group manager, integrated solutions for Beckman Coulter.

About the company

Beckman Coulter, Inc., based in Fullerton, California, develops, manufactures and markets products that simplify, automate and innovate complex biomedical tests. More than 200,000 Beckman Coulter systems operate in laboratories around the world supplying critical information for improving patient health and reducing the cost of care. Recurring revenue, consisting of supplies, test kits, service and operating-type lease payments, represents more than 75 percent of the company’s 2006 annual revenue of $2.53 billion.

For more information, visit www.beckmancoulter.com.

Link to this release at:
http://www.beckman.com/HR/PressRoom/oc_pressReleases_detail.asp?Key=8533

Please send READER INQUIRIES from this news release directly to Beckman Coulter, c/o K. Delgado, Harte Hanks, 1753 South Pointe Avenue, Ontario, CA 91761. Or e-mail to k_delgado@harte-hanks.com.